Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Equity fundraise

7 Oct 2025 07:00

RNS Number : 2833C
Insig AI Plc
07 October 2025
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this information is considered to be in the public domain.

 

Insig AI plc

("Insig AI", the "Company" or the "Group")

 

 

Equity fundraise

 

Insig AI plc (AIM:INSG), a provider of AI-led analytics and machine learning solutions is pleased to announce that following receipt of an unsolicited offer of equity investment, it has raised gross proceeds of approximately £500,000 at 30p per ordinary share of 1 pence each ("Ordinary Share") (the "Placing"). The placing price represents a discount of 7.41% to the closing share price on 6 October 2025 of 32.4p. The Placing proceeds will be used for general working capital purposes including bolstering Insig's sales activities and the continuing evaluation of the Company's strategic options including the potential establishment of a fund dedicated to investments in digital assets and related enterprises. The Placing will be satisfied by the issue of 1,666,666 Ordinary Shares (the "Placing Shares"). CMC Markets UK Plc ("CMC"), trading as CapX, acted as the Company's sole placing agent in respect of the Placing.

 

 

Insig AI is also pleased to report that unaudited revenues for the six months to 30 September 2025 were circa £421k, more than 155% ahead of the equivalent period last year (£165k). This represents a further acceleration from the three months to 30 June 2025, where comparable sales growth was 143%.

 

Insig AI is also pleased to announce that CMC has been appointed as the Company's joint corporate broker.

 

Admission and Total Voting Rights

 

Application will be made to the London Stock Exchange for admission of the Placing Shares to trading on AIM ("Admission"). Admission is expected to become effective, and dealings in the Subscription Shares are anticipated to commence on or around 13 October 2025.

 

Following Admission, the issued share capital and total voting rights of the Company will be 123,349,309. Shareholders may use this figure as the denominator to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Richard Bernstein, Chief Executive commented: "We're pleased to have attracted this offer of equity capital. It enables us to allocate further resource towards the evaluation of strategic options including the potential establishment of a fund dedicated to digital assets and related enterprises as well as being able to invest for additional sales growth from our current and planned new product offerings. Furthermore, with these various initiatives and evaluations taking shape, now is the time to have CMC Markets, with its impressive reach and market positioning, as our joint broker."

 

 

For further information, please visit www.insig-ai.com or contact:

 

Insig AI plc

Richard Bernstein, CEO

richard.bernstein@insg.ai

 

Zeus (Nominated Adviser & Joint Broker)

David Foreman / James Hornigold

+44 (0) 203 829 5000

 

CMC Markets (Joint Broker)

Douglas Crippen + 44 (0) 203 003 8632

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAFEKEEASFAA
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.